Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
48.23
-1.75 (-3.50%)
At close: Mar 28, 2025, 4:00 PM
48.34
+0.11 (0.23%)
After-hours: Mar 28, 2025, 7:58 PM EDT

Pro-Dex Revenue

Pro-Dex had revenue of $16.79M in the quarter ending December 31, 2024, with 33.40% growth. This brings the company's revenue in the last twelve months to $61.00M, up 26.45% year-over-year. In the fiscal year ending June 30, 2024, Pro-Dex had annual revenue of $53.84M with 16.83% growth.

Revenue (ttm)
$61.00M
Revenue Growth
+26.45%
P/S Ratio
2.67
Revenue / Employee
$412,189
Employees
148
Market Cap
157.28M

Revenue Chart

Created with Highcharts 11.4.8Pro-Dex Revenue - Annual34.83M34.83M38.03M38.03M42.04M42.04M46.09M46.09M53.84M53.84M20202021202220232024-10M20M30M40M50M

History

Fiscal Year End Revenue Change Growth
Jun 30, 202453.84M7.76M16.83%
Jun 30, 202346.09M4.05M9.62%
Jun 30, 202242.04M4.01M10.55%
Jun 30, 202138.03M3.20M9.17%
Jun 30, 202034.83M7.66M28.20%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings